Literature DB >> 17344052

Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress.

F Celsi1, M Svedberg, C Unger, C W Cotman, M T Carrì, O P Ottersen, A Nordberg, R Torp.   

Abstract

Calcineurin is an abundant cytosolic protein that is implicated in the modulation of glutamate release. Here we show that the expression level of this enzyme is reduced in primary neuronal cultures treated with beta-amyloid. Parallel experiments in ETNA cell lines expressing SOD1 suggested that the effect of beta-amyloid on calcineurin expression is mediated by oxidative stress. The relevance of the in vitro experiments was assessed by analysis of tissue from patients with Alzheimer's disease (AD) and tissue from two strains of transgenic mice that mimic aspects of AD. The tissue from the AD brains displayed a pronounced downregulation of calcineurin immunoreactivity in profiles that were negative for glial fibrillary acidic protein (GFAP). In the hippocampus of the transgenic animals (which were analyzed in an early stage of the disease) the downregulation of calcineurin was restricted to mossy fiber terminals. A downregulation of the presynaptic pool of calcineurin may contribute to the dysregulation of glutamate release that is considered a hallmark of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344052     DOI: 10.1016/j.nbd.2006.12.022

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  29 in total

1.  Mechanism of okadaic acid-induced neuronal death and the effect of estrogens.

Authors:  Kun Don Yi; Douglas F Covey; James W Simpkins
Journal:  J Neurochem       Date:  2008-11-28       Impact factor: 5.372

Review 2.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.

Authors:  Ilya Bezprozvanny; Mark P Mattson
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

3.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

4.  Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.

Authors:  Matthew J Chiocco; Xuguang Zhu; Donna Walther; Olga Pletnikova; Juan C Troncoso; George R Uhl; Qing-Rong Liu
Journal:  Subst Use Misuse       Date:  2010-09       Impact factor: 2.164

5.  Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats.

Authors:  Yeye Zhuo; Haibiao Guo; Yufang Cheng; Chuang Wang; Canmao Wang; Jingang Wu; Zhengqiang Zou; Danna Gan; Yiwen Li; Jiangping Xu
Journal:  Metab Brain Dis       Date:  2016-02-27       Impact factor: 3.584

Review 6.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 7.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

8.  Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?

Authors:  Kelsey E McLimans; Bridget E Clark; Alexandra Plagman; Colleen Pappas; Brandon Klinedinst; Vellareddy Anatharam; Anumantha Kanthasamy; Auriel A Willette
Journal:  Antioxid Redox Signal       Date:  2019-06-26       Impact factor: 8.401

9.  Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.

Authors:  Jennifer L Furman; Diana M Sama; John C Gant; Tina L Beckett; M Paul Murphy; Adam D Bachstetter; Linda J Van Eldik; Christopher M Norris
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

10.  Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.

Authors:  Hafiz Mohmmad Abdul; Michelle A Sama; Jennifer L Furman; Diana M Mathis; Tina L Beckett; Adam M Weidner; Ela S Patel; Irfan Baig; M Paul Murphy; Harry LeVine; Susan D Kraner; Christopher M Norris
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.